Trade Summary

6 days ago, Bienaime Jean Jacques, serving as Dir at Immunome Inc. (IMNM), purchased 5,000 shares at $20.70 per share, for a total transaction value of $103,500.00. Following this transaction, Bienaime Jean Jacques now holds 43,415 shares of IMNM.

This purchase represents a 13.00% increase in Bienaime Jean Jacques's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 15, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 19, 2026 at 7:56 AM ET, 4 days after the trade was made.

Immunome Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.